Rapid Communication
Copyright ©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 21, 2007; 13(7): 1074-1078
Published online Feb 21, 2007. doi: 10.3748/wjg.v13.i7.1074
Hepatitis C risk assessment, testing and referral for treatment in urban primary care: Role of race and ethnicity
Stacey B Trooskin, Victor J Navarro, Robert J Winn, David J Axelrod, A Scott McNeal, Maricruz Velez, Steven K Herrine, Simona Rossi
Stacey B Trooskin, Victor J Navarro, Maricruz Velez, Steven K Herrine, Simona Rossi, Division of Gastroenterology and Hepatology, Thomas Jefferson University, Philadelphia, PA 19107, United States
Robert J Winn, Department of Family Medicine, Thomas Jefferson University, Philadelphia, PA 19107, United States
David J Axelrod, Division of Internal Medicine, Thomas Jefferson University, Philadelphia, PA 19107, United States
A Scott McNeal, Delaware Valley Community Health Inc., Philadelphia, PA 19107, United States
Author contributions: All authors contributed equally to the work.
Supported by an educational grant from Roche
Correspondence to: Dr. Victor Navarro, Thomas Jefferson University, Division of Gastroenterology and Hepatology, 132 South 10th Street, Suite 480 Main Building, Philadelphia, PA 19107, United States. victor.navarro@jefferson.edu
Telephone: +1-215-9555271
Received: November 15, 2006
Revised: December 15, 2006
Accepted: January 26, 2007
Published online: February 21, 2007
Abstract

AIM: To determine rates of hepatitis C (HCV) risk factor ascertainment, testing, and referral in urban primary care practices, with particular attention to the effect of race and ethnicity.

METHODS: Retrospective chart review from four primary care sites in Philadelphia; two academic primary care practices and two community clinics was performed. Demographics, HCV risk factors, and other risk exposure information were collected.

RESULTS: Four thousand four hundred and seven charts were reviewed. Providers documented histories of injection drug use (IDU) and transfusion for less than 20% and 5% of patients, respectively. Only 55% of patients who admitted IDU were tested for HCV. Overall, minorities were more likely to have information regarding a risk factor documented than their white counterparts (79% vs 68%, P < 0.0001). Hispanics were less likely to have a risk factor history documented, compared to blacks and whites (P < 0.0001). Overall, minorities were less likely to be tested for HCV than whites in the presence of a known risk factor (23% vs 35%, P = 0.004). Among patients without documentation of risk factors, blacks and Hispanics were more likely to be tested than whites (20% and 24%, vs 13%, P < 0.005, respectively).

CONCLUSION: (1) Documentation of an HCV risk factor history in urban primary care is uncommon, (2) Racial differences exist with respect to HCV risk factor ascertainment and testing, (3) Minority patients, positive for HCV, are less likely to be referred for subspecialty care and treatment. Overall, minorities are less likely to be tested for HCV than whites in the presence of a known risk factor.

Keywords: Hepatitis C, Minority groups, Urban health, Primary health care, Risk assessment